Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
2022 · The Lancet Oncology · 150 citations
https://doi.org/10.1016/s1470-2045(22)00613-1
S
Simona F. Shaitelman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
264
Papers
7.0K
Citations
38
h-index
115
i10-index
Simona F. Shaitelman is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Radiotherapy Techniques & Breast Lesions and Carcinomas. The author has an h-index of 38, co-authored 225 publications.
ORCID: 0000-0002-7697-1263Papers by this author
worksPartial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline
2023 · Practical Radiation Oncology · 146 citations
https://doi.org/10.1016/j.prro.2023.11.001
Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy
2015 · Annals of Surgical Oncology · 136 citations
https://doi.org/10.1245/s10434-015-4921-5
Five‐year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation
2010 · Cancer · 84 citations
https://doi.org/10.1002/cncr.25383
Optimizing MR-Guided Radiotherapy for Breast Cancer Patients
2020 · Frontiers in Oncology · 58 citations
https://doi.org/10.3389/fonc.2020.01107
Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy
2025 · New England Journal of Medicine · 52 citations
https://doi.org/10.1056/nejmoa2414859
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat